Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 9 of 100
Leadership
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By
AFP
November 7, 2024
Lifestyle
Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness
By
Ryan Hogg
November 4, 2024
Finance
Jo Natauri’s Invidia Capital seeks $850 million for first fund
By
Luisa Beltran
October 31, 2024
Retail
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By
AFP
October 30, 2024
Health
Novo’s main Ozempic plant cited for quality lapses by FDA
By
Madison Muller
and
Bloomberg
October 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
By
Alexa Mikhail
October 29, 2024
Finance
Sanofi profit lifted by early vaccine sales, dupixent growth
By
Ashleigh Furlong
,
Tim Loh
and
Bloomberg
October 25, 2024
Commentary
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By
Jeffrey Sonnenfeld
and
Steven Tian
October 24, 2024
Health
Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By
Lindsey Leake
October 22, 2024
Leadership
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
By
John Kell
October 22, 2024
Health
French government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue
By
Jurgen Hecker
,
Tom Barfield
and
AFP
October 22, 2024
Leadership
23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By
Lila MacLellan
October 17, 2024
Commentary
The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
By
Jano Costard
October 16, 2024
Health
Walgreens to close 1,200 stores over next three years
By
Chris Morris
October 15, 2024
Retail
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By
Jurgen Hecker
and
AFP
October 15, 2024
Most Popular
Economy
'Some form of crisis is almost inevitable': The $38 trillion national debt will soon be growing faster than the U.S....
By
Nick Lichtenberg
Success
Nvidia CEO Jensen Huang says ‘a lot’ of six-figure jobs in plumbing and construction are about to be unlocked because...
By
Preston Fore
Politics
Jamie Dimon tells Davos: ‘You didn’t do a particularly good job making the world a better place’
By
Eleanor Pringle